 |
Publisher: Peytchinski Publishing Ltd.
ISSN: 1312-773X (Online)
Issue: 2025, vol. 31, issue2
Subject Area: Medicine
-
DOI: 10.5272/jimab.2025312.6143
Published online: 15 April 2025
Case report
J of IMAB. 2025 Apr-Jun;31(2):6143-6148
PERFORMING GONADECTOMY IN A 15-YEAR-OLD BULGARIAN GIRL WITH COMPLETE ANDROGEN INSENSITIVITY SYNDROME: A CASE REPORT
Diana Hristova
, Radko Tocev, Krassimir Neykov, Ibryam Ibryam, Sergei Slavov, Smail Smail,
Department of Obstetrics and Gynecology, Medical University Sofia, University Obstetrics and Gynecology Hospital "Maichin dom" Sofia, Bulgaria.
ABSTRACT:
Complete Androgen Insensitivity Syndrome (CAIS) is a rare genetic Disorder of Sex Development linked to the X chromosome. It occurs due to mutations—either from mother inheritance or arising spontaneously—in the androgen receptor (AR) gene, located in the Xq11-q12 region.
Individuals with CAIS have a 46, XY karyotype, meaning they are genetically male. However, due to a complete inability of their body's tissues to respond to androgens, they develop female external genitalia. Internally, they have fully formed but undescended testes and their bodies do not develop male reproductive structures. Diagnosis typically involves genetic testing, hormone analysis, and imaging to assess the presence of testes.
This is a case report of a 15-year-old female-looking Bulgarian patient with primary amenorrhea who underwent prophylactic gonadectomy after ultrasound examination and MRI was performed. From the performed imaging studies, Sertoli cell adenoma was suspected. Histological findings were rudimentary testicles with the presence of paratesticular cysts (more prominent on the left). Rudimentary Fallopian tubes were also present. The patient's karyotype was 46, XY without any evidence of aberrations.
A precise algorithm should be established for diagnosis, treatment and prevention for patients with CAIS, in order to improve the quality of life and prognosis. The key, in our opinion, is the multidisciplinary approach and the creation of specialized centers for children with rare genetic disorders.
Keywords: Complete androgen insensitivity syndrome (CAIS), Sertoli cell adenoma, hormonal replacement therapy, persistence of Fallopian tubes in CAIS,
- Download FULL TEXT /PDF 1383 KB/
Please cite this article as: Hristova D, Tocev R, Neykov K, Ibryam I, Slavov S, Smail S. Performing gonadectomy in a 15-year-old Bulgarian girl with Complete androgen insensitivity syndrome: a case report. J of IMAB. 2025 Apr-Jun;31(2):6143-6148. [Crossref - 10.5272/jimab.2025312.6143]
Correspondence to: Diana Hristova, Department of Obstetrics and Gynecology, Medical Faculty, Medical University – Sofia; University Obstetrics and Gynecology Hospital "Maichin dom" Sofia; 2, Zdrave Str., Sofia, Bulgaria; E-mail: didna@abv.bg
REFERENCES:
1. Hughes IA, Werner R, Bunch T, Hiort O. Androgen insensitivity syndrome. Semin Reprod Med. 2012 Oct;30(5):432-42 [PubMed]
2. Mongan NP, Tadokoro-Cuccaro R, Bunch T, Hughes IA. Androgen insensitivity syndrome. Best Pract Res Clin Endocrinol Metab. 2015 Aug;29(4):569-80. [ target="_blank"PubMed]
3. Boehmer AL, Brinkmann O, Brüggenwirth H, van Assendelft C, Otten BJ, Verleun-Mooijman MC, et al. Genotype versus phenotype in families with androgen insensitivity syndrome. J Clin Endocrinol Metab. 2001 Sep;86(9):4151-60. [PubMed]
4. Oakes MB, Eyvazzadeh AD, Quint E, Smith YR. Complete androgen insensitivity syndrome--a review. J Pediatr Adolesc Gynecol. 2008 Dec;21(6):305-10. [PubMed]
5. Gulía C, Baldassarra S, Zangari A, Briganti V, Gigli S, Gaffi M, et al. Androgen insensitivity syndrome. Eur Rev Med Pharmacol Sci. 2018 Jun;22(12):3873-3887. [PubMed]
6. Batista RL Costa EMF, Rodrigues AS, Gomes NL, Faria JA Jr, Nishi MY, et al. Androgen insensitivity syndrome: a review. Arch Endocrinol Metab. 2018 Mar-Apr;62(2):227-235. [PubMed ]
7. Dey R, Biswas SC, Chattopadhvav N, Gupta D, RoyBiswas R, Mukhopadhyay A. The XY Female (Androgen Insensitivity Syndrome)—Runs in the Family. J Obstet Gyneco. India. 2012 Jun;62(3):332-3 [PubMed]
8. Gottlieb B, Trifiro MA. Androgen Insensitivity Syndrome. 1999 Mar 24 [updated 2017 May 11]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. [PubMed]
9. Dei M, Bruni V. Pediatric and adolescent gynaecology. OEO. 2023; pp.195-199. [Internet]
10. Deans R, Creighton SM, Liao LM, Conway GS. Timing of gonadectomy in adult women with complete androgen insensitivity syndrome (CAIS): Patient preferences and clinical evidence. Clin Endocrinol (Oxf). 2012 Jun;76(6):894-8 [PubMed]
11. Lutke Holzik MF, Sijmons RH, Hoekstra-Weebers JE, Sleijfer DT, Hoekstra HJ. Clinical and genetic aspects of testicular germ cell tumours. Hered Cancer Clin Pract. 2008 Feb 15;6(1):3-14. [PubMed]
12. Cools M, Wolffenbuttel KP, Hersmus R, Mendonca BB, Kaprová J, Drop SLS, et al. Malignant testicular germ cell tumors in postpubertal individuals with androgen insensitivity: Prevalence, pathology and relevance of single nucleotide polymorphism-based susceptibility profiling. Hum Reprod. 2017 Dec 1;32(12):2561-2573 [PubMed]
13. Kravarusic D, Seguier-Lipszyc E, Feigin E, Nimri R, Nagelberg N, Freud E. Androgen insensitivity syndrome: Risk of malignancy and timing of surgery in a paediatric and adolescent population. Afr J Paediatr Surg. 2011 May-Aug;8(2):194-8. [PubMed]
14. Cools M, Looijenga L. Update on the Pathophysiology and Risk Factors for the Development of Malignant Testicular Germ Cell Tumors in Complete Androgen Insensitivity Syndrome. Sex Dev. 2017; 11(4):175-181. [PubMed]
15. Weidler EM, Linnaus ME, Baratz AB, Goncalves LF, Bailey S, Hernandez SJ, et al. A Management Protocol for Gonad Preservation in Patients with Androgen Insensitivity Syndrome. J Pediatr Adolesc Gynecol. 2019 Dec;32(6):605-611. [PubMed]
16. Dieckmann KP, Simonsen-Richter H, Kulejewski M, Anheuser P, Zecha H, Isbarn H, et al. Serum Tumour Markers in Testicular Germ Cell Tumours: Frequencies of Elevated Levels and Extents of Marker Elevation Are Significantly Associated with Clinical Parameters and with Response to Treatment. Biomed Res Int. 2019 May 28;2019:5030349. [PubMed]
Received: 13 September 2024
Published online: 15 April 2025